Avricore Health Stock Shares Outstanding
| AVCR Stock | CAD 0.08 0.01 14.29% |
Avricore Health fundamentals help investors to digest information that contributes to Avricore Health's financial success or failures. It also enables traders to predict the movement of Avricore Stock. The fundamental analysis module provides a way to measure Avricore Health's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Avricore Health stock.
Common Stock Shares Outstanding is likely to climb to about 104.6 M in 2024. Avricore | Shares Outstanding |
Avricore Health Company Shares Outstanding Analysis
Avricore Health's Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted basis, including exotic instruments such as options, or convertibles bonds.
Current Avricore Health Shares Outstanding | 100.94 M |
Most of Avricore Health's fundamental indicators, such as Shares Outstanding, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Avricore Health is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Avricore Shares Outstanding Driver Correlations
Understanding the fundamental principles of building solid financial models for Avricore Health is extremely important. It helps to project a fair market value of Avricore Stock properly, considering its historical fundamentals such as Shares Outstanding. Since Avricore Health's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Avricore Health's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Avricore Health's interrelated accounts and indicators.
Click cells to compare fundamentals
Outstanding shares that are stated on company Balance Sheet are used when calculating many important valuation and performance indicators including Return on Equity, Market Cap, EPS and many others.
| Competition |
Avricore Common Stock Shares Outstanding
Common Stock Shares Outstanding |
|
Based on the latest financial disclosure, Avricore Health has 100.94 M of shares currently outstending. This is 44.09% lower than that of the Biotechnology sector and 74.87% lower than that of the Health Care industry. The shares outstanding for all Canada stocks is 82.35% higher than that of the company.
Avricore Shares Outstanding Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Avricore Health's direct or indirect competition against its Shares Outstanding to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Avricore Health could also be used in its relative valuation, which is a method of valuing Avricore Health by comparing valuation metrics of similar companies.Avricore Health is currently under evaluation in shares outstanding category among its peers.
Avricore Health Current Valuation Drivers
We derive many important indicators used in calculating different scores of Avricore Health from analyzing Avricore Health's financial statements. These drivers represent accounts that assess Avricore Health's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Avricore Health's important valuation drivers and their relationship over time.
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Market Cap | 1.4M | 5.7M | 14.8M | 30.8M | 16.9M | 17.8M | |
| Enterprise Value | 1.4M | 6.4M | 12.8M | 30.2M | 16.7M | 17.5M |
Avricore Fundamentals
| Return On Equity | -0.0014 | ||||
| Return On Asset | 0.0151 | ||||
| Profit Margin | (0.0007) % | ||||
| Operating Margin | 0.07 % | ||||
| Current Valuation | 7.83 M | ||||
| Shares Outstanding | 100.94 M | ||||
| Shares Owned By Insiders | 10.19 % | ||||
| Number Of Shares Shorted | 5.75 K | ||||
| Price To Book | 3.24 X | ||||
| Price To Sales | 1.80 X | ||||
| Revenue | 3.49 M | ||||
| Gross Profit | 30.52 K | ||||
| EBITDA | 517.7 K | ||||
| Net Income | (701.22 K) | ||||
| Cash And Equivalents | 122.09 K | ||||
| Total Debt | 40 K | ||||
| Current Ratio | 1.80 X | ||||
| Book Value Per Share | 0.02 X | ||||
| Cash Flow From Operations | 660.4 K | ||||
| Short Ratio | 0.02 X | ||||
| Beta | -1.89 | ||||
| Market Capitalization | 8.08 M | ||||
| Total Asset | 2.54 M | ||||
| Retained Earnings | (31.74 M) | ||||
| Working Capital | 244.34 K | ||||
| Net Asset | 2.54 M |
About Avricore Health Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Avricore Health's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Avricore Health using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Avricore Health based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Avricore Stock Analysis
When running Avricore Health's price analysis, check to measure Avricore Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Avricore Health is operating at the current time. Most of Avricore Health's value examination focuses on studying past and present price action to predict the probability of Avricore Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Avricore Health's price. Additionally, you may evaluate how the addition of Avricore Health to your portfolios can decrease your overall portfolio volatility.